VENTRIPOINT DIAGNOSTICS LTD

Ventripoint Diagnostics (VPT.V) sits flat at CAD 0.09, offering investors a stable niche in 3‑D heart‑disease diagnostics with AI‑driven future growth and U.S. expansion plans.

Ventripoint Diagnostics drops 10% to CAD 0.09 as a Calgary‑based heart‑disease imaging tech struggles in a weak market, despite a strong 52‑week high.

TSX Venture sees Ventripoint Diagnostics climb 5.56% as investors spot growth in heart‑disease imaging tech, poised for future catalysts.